Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3518 publications
Downregulation of SFRP1 in Enzalutamide-Resistance Prostate Cancer is Associated with Angiogenesis and Regulatory T Cell Infiltration.
Journal: Archivos espanoles de urologia
Published: October 20, 2025
Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer.
Journal: NEJM evidence
Published: October 16, 2025
Protein disulfide isomerases regulate androgen receptor stability and promote prostate cancer cell growth and survival.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 14, 2025
Allosteric Cooperativity Mechanism Investigation of Orthosteric and Allosteric Ligands in Modulating AR Activity: A Molecular Dynamics Study.
Journal: Journal of chemical information and modeling
Published: October 13, 2025
Role of Porous Silicates in Balancing Drug Loading, Stability, and Pharmacokinetics of Enzalutamide Supersaturated Lipid-Based Formulations.
Journal: Molecular pharmaceutics
Published: October 11, 2025
French recommendations from the AFU Cancer Committee for prostate cancer 2025 Summary of changes.
Journal: The French journal of urology
Published: October 06, 2025
PARP inhibitors (poly-ADP-ribose polymerase) : newcomers in the management of prostate cancers
Journal: Revue medicale de Liege
Published: September 11, 2025
Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition.
Journal: The Journal of clinical investigation
Published: September 04, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.
Journal: Research square
Published: September 02, 2025
Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: August 30, 2025
Last Updated: 10/31/2025